Home

Bylaws

Officers

Newsletter

Membership

Students/Post-Docs

Symposia

Annual Report

 

National Capital Area Chapter Society of Toxicology

Serving Toxicologists in Maryland, Virginia and the District of Columbia

Symposia

 

Past NCAC-SOT symposia

 

 

Biomarkers of Drug Safety: Discovery
and Regulatory Aspects

 

National Capital Area Chapter

Society of Toxicology

Fall Symposium

November 6, 2007

Lister Hill Auditorium

National Library of Medicine

Bethesda, MD

 

Program

 

8:30 a.m.                    Registration and Continental Breakfast

 

9:00 a.m.                    Welcome/Opening Remarks

                                    Gary Burin, Ph.D.

                                    President, NCAC-SOT

 

                                    Donna Mendrick, Ph.D.

Vice-President, NCAC-SOT and Program Chair

 

9:10 a.m.                    Computational Framework to Predict Toxicity and Prioritize Testing of Environmental Chemicals

Thomas B. Knudsen, Ph.D.

Developmental Systems Biologist (title 42)

National Center for Computational Toxicology

Office of Research & Development
U.S. Environmental Protection Agency
Research Triangle Park, NC

 

10:00 a.m.                  Experience with a Biomarker Consortium

William Mattes, Ph.D., D.A.B.T.

                                    Director of Toxicology

                                    The Critical Path Institute

                                    Rockville, MD

 

10:50 a.m.                  Break

 

11:10 a.m.                  A Year of Working through a Biomarker Qualification Pilot Process at the FDA

Federico Goodsaid, Ph.D.

                                    Genomics Group

                                    Office of Clinical Pharmacology

                                    Office of Translational Science

                                    Center for Drug Evaluation and Research. U.S. Food and Drug Administration

                                    Silver Spring, MD

 

12:00 p.m.                  Lunch (Box lunch and beverage included in registration fee)

 

1:00 p.m.                    Bridging Exploratory Biomarkers into Drug Development

Joseph Sina, Ph.D.

                                    Senior Scientific Director, Systems Toxicology

                                    Department of Safety Assessment

                                    Mereck & Co., Inc.

                                    West Point, PA

 

1:50 p.m.                    Break

 

2:10 p.m.                    Thinking About How a Preclinical Program Can Translate into the Clinic

Jerry M. Collins, Ph.D.

                                    Associate Director for Developmental Therapeutics

                                    Division of Cancer Treatment and Diagnosis, NCI, NIH

                                    Bethesda, MD

 

3:00 p.m.                    Monitoring Genetic Toxicity Indicators in Clinical Trials: Pros and Cons

David Jacobson-Kram, Ph.D., D.A.B.T.

                                    Associate Director for Pharmacology and Toxicology

                                    Office of New Drugs

                                    Center for Drug Evaluation and Research

                                    Silver Spring, MD 20993

 

3:50 p.m.                    Closing Remarks

                                    Donna Mendrick, Ph.D.

                                    Vice-President, NCAC-SOT and Program Chair

 

4:00 p.m.                    Meeting Adjourned

 

 

SPEAKER SLIDE PRESENTATIONS (In Adobe Acrobat®)


Past NCAC-SOT Symposia

  (Click on date to view program: not all programs available yet)

 

  • Spring 2007  “The Role of Inflammation in Toxicity” (includes speaker abstracts and slide presentations)
  • Fall 2006  “Computational Toxicology”
  • Spring 2006  “Public Health Concerns in Disaster Preparedness” (includes speaker abstracts and slide presentations)
  • Fall 2005  “Biological, Toxicological, and Regulatory Assessment of Nano-Materials” (includes speaker abstracts)
  • Spring 2005  “Toxicology of Chemical Mixtures” (includes speaker abstracts and slide presentations)
  • Fall 2004  “Toxicology of Dietary Supplements” (includes speaker abstracts and slide presentations)
  • Spring 2004  Novel Methods for Detecting Hepatotoxic Agents” (Includes speaker abstracts and slide presentations)
  • Fall 2003  “Animal Models for Safety and Efficacy Testing of Agents that Cannot be Tested in Humans”
  • Spring 2003  “Emerging Issues in Human and Veterinary Pharmaceutical Contamination of Water Supplies”
  • Fall 2002  Potential Applications of Noninvasive Techniques to Toxicology”
  • Spring 2002  “The Dose Response – The Cornerstone of Toxicology and Challenges for Risk Assessment”
  • Fall 2001
  • Spring 2001
  • Fall 2000  “Computational Approaches for Predicting the Toxicity of Chemicals”
  • Spring 2000  “Translating Genomics and Proteomics for Toxicology and Risk Assessment”
  • Fall 1999  “Toxicology and Risk Communication”

 

Back to the top

 

Home Page | Newsletter | Students/Postdocs | Officers | Membership | Bylaws | Symposia | Annual Report

 

Last updated, November 20, 2007